Literature DB >> 24158113

Can Giardia lamblia infection lower the risk of acute diarrhea among preschool children?

Khitam Muhsen1, Dani Cohen, Myron M Levine.   

Abstract

There are inconsistent findings concerning the role of Giardia lamblia in pediatric diarrhea. A prospective cohort study of the incidence of acute diarrhea among Israeli Arab preschool children offered the opportunity to examine the association between G. lamblia infection (at baseline) and subsequent diarrhea. Following baseline screening by light microscopy for the presence of Giardia in their stools, a cohort was assembled of 142 children who were followed between October 2003 and August 2004 for the incidence of diarrhea. Surveillance was performed through maternal interviews. At baseline, 21 children tested Giardia-positive. During the prospective surveillance, acute diarrhea occurred less often among Giardia-positive children (9.5%) than among children who were not infected with Giardia (26.5%). G. lamblia infection was associated with lower risk of acute diarrhea; adjusted odds ratio of 0.18 (95% confidence interval 0.04-0.93) (p = 0.041). This prospective study provides additional evidence that Giardia may lower the risk of subsequent acute diarrhea among preschool children.

Entities:  

Keywords:  Giardia; diarrhea; preschool; prospective study; risk

Mesh:

Year:  2013        PMID: 24158113     DOI: 10.1093/tropej/fmt085

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  23 in total

Review 1.  Giardia: a pathogen or commensal for children in high-prevalence settings?

Authors:  Luther A Bartelt; James A Platts-Mills
Journal:  Curr Opin Infect Dis       Date:  2016-10       Impact factor: 4.915

2.  Molecular and epidemiological characterization of Giardia Intestinalis assemblages detected in Djelfa, Algeria.

Authors:  Nadjat Rebih; Saad Boutaiba; Ghalia Aboualchamat; Karim Souttou; Ahcen Hakem; Samar Al Nahhas
Journal:  J Parasit Dis       Date:  2020-03-13

3.  Human Memory CD4+ T Cell Immune Responses against Giardia lamblia.

Authors:  Christina Skår Saghaug; Steinar Sørnes; Dimitra Peirasmaki; Staffan Svärd; Nina Langeland; Kurt Hanevik
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

Review 4.  Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota.

Authors:  Thibault Allain; Christina B Amat; Jean-Paul Motta; Anna Manko; André G Buret
Journal:  Tissue Barriers       Date:  2017-01-03

Review 5.  What's eating you? An update on Giardia, the microbiome and the immune response.

Authors:  Steven M Singer; Vanessa V Angelova; Heriberto DeLeon; Eleanor Miskovsky
Journal:  Curr Opin Microbiol       Date:  2020-10-11       Impact factor: 7.934

6.  Giardia duodenalis cathepsin B proteases degrade intestinal epithelial interleukin-8 and attenuate interleukin-8-induced neutrophil chemotaxis.

Authors:  James A Cotton; Amol Bhargava; Jose G Ferraz; Robin M Yates; Paul L Beck; Andre G Buret
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

7.  Giardia lamblia: Laboratory Maintenance, Lifecycle Induction, and Infection of Murine Models.

Authors:  Marc Y Fink; Danielle Shapiro; Steven M Singer
Journal:  Curr Protoc Microbiol       Date:  2020-06

Review 8.  Advances in understanding Giardia: determinants and mechanisms of chronic sequelae.

Authors:  Luther A Bartelt; R Balfour Sartor
Journal:  F1000Prime Rep       Date:  2015-05-26

Review 9.  Disruptions of Host Immunity and Inflammation by Giardia Duodenalis: Potential Consequences for Co-Infections in the Gastro-Intestinal Tract.

Authors:  James A Cotton; Christina B Amat; Andre G Buret
Journal:  Pathogens       Date:  2015-11-10

10.  A Prospective Longitudinal Cohort to Investigate the Effects of Early Life Giardiasis on Growth and All Cause Diarrhea.

Authors:  Jeffrey R Donowitz; Masud Alam; Mamun Kabir; Jennie Z Ma; Forida Nazib; James A Platts-Mills; Luther A Bartelt; Rashidul Haque; William A Petri
Journal:  Clin Infect Dis       Date:  2016-06-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.